Abstract
Background: with improved treatment and decreased mortality in the last decades, atherosclerotic vascular disease and its complications have been identified as an important cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Studies have shown a correlation between adipokine levels and cardiovascular risk factors, with possible immunomodulatory role of th…